DOI: 10.4155/bio-2023-0095 ISSN:
Upfront acid treatment with low final pH: the development and testing of a novel method to improve drug tolerance in antidrug antibody assays
Justin K Mack, Nicoletta Bivi- Medical Laboratory Technology
- Clinical Biochemistry
- General Pharmacology, Toxicology and Pharmaceutics
- General Medicine
- Analytical Chemistry
Background: The drug tolerance of an antidrug antibody (ADA) assay for a therapeutic monoclonal antibody was insufficient to meet the level of biotherapeutic expected in sera, and a typical acid dissociation method was inadequate. Other strategies were investigated to dissociate ADA–drug complexes and thereby improve drug tolerance. Results: Having a lower final pH of samples after acid dissociation was shown to greatly improve drug tolerance. This method was shown to improve drug tolerance in the ADA assays for four additional monoclonal antibodies and to better detect ADAs in clinical samples. Conclusion: These findings provide a novel alternative method for improving drug tolerance when other methods are not sufficient.